Article
SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults.
European journal of endocrinology - 1 Jan 2014
Glad Camilla A M, Barbosa Edna J L, Filipsson Nyström Helena, Carlsson Lena M S, Nilsson Staffan, Nilsson Anna G, Svensson Per-Arne, Johannsson Gudmundur
Abstract excerpt
OBJECTIVE: GH-deficient (GHD) adults have reduced serum concentrations of IGF1. GH replacement therapy increases serum IGF1 concentrations, but the interindividual variation in treatment response is large and likely influenced by genetic factors. This study was designed to test the hypothesis that single-nucleotide polymorphisms (SNPs) in genes within the GH signaling pathway influence the serum IGF1 response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
